JNJ vs WFC: Which Is the Better Buy?
Side-by-side comparison of Johnson & Johnson and Wells Fargo & Company — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-17.
Johnson & Johnson · Healthcare
$253.85
-21.7% upside to fair value
Grade D
High Quality
VS
Wells Fargo & Company · Financial Services
$87.53
+18.1% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
WFC has more upside to fair value
(+18.1%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
JNJ |
WFC |
| Current Price |
$253.85 |
$87.53 |
| Fair Value Estimate |
$198.76 |
$103.38 |
| Upside to Fair Value |
-21.7%
|
+18.1%
|
| Market Cap |
$611.1B |
$267.8B |
| Forward P/E |
29.3x
|
—
|
| EV / EBITDA |
19.2x
|
15.8x
|
| Price / Sales |
6.3x
|
2.1x
|
| Price / FCF |
34.3x
|
226.4x
|
| Revenue Growth YoY |
+9.9%
|
+11.3%
|
| Gross Margin |
69.1%
|
64.5%
|
| Operating Margin |
26.9%
|
21.2%
|
| Return on Equity |
26.3%
|
12.6%
|
| Dividend Yield |
0% |
2.06% |
| FCF Yield |
2.91%
|
0.44%
|
| Analyst Consensus |
Buy
|
Hold
|
Investment Thesis
Johnson & Johnson is a leading healthcare conglomerate operating primarily in the drug manufacturing sector, known for its durable competitive moat supported by strong brand recognition and intangible assets. The company exhibits high business quality with a 26.3% return on equity and robust gross and net margins of 69.1% and 21.8%, respectively. However, earnings have faced significant pressure,…
Wells Fargo is a diversified U.S. bank operating consumer and commercial banking, corporate and investment banking, and wealth management, supported by a large deposit franchise, a $2.3 trillion asset base, nationwide advisory distribution, and increasingly relevant capital-markets capabilities. Business quality is high but not without legacy constraints: return on equity is 12.6%, gross margin i…
Accumulation Zones
| Metric |
JNJ |
WFC |
| Zone Low |
$149.07 |
$77.53 |
| Zone High |
$168.95 |
$87.87 |
| In Buy Zone? |
No
|
Yes
|